Answers are grounded in this paper and cite their sources.
Atopic dermatitis (AD) is a chronic inflammatory skin disease associated with mitochondrial oxidative stress and metabolic dysregulation. This study investigated the anti-inflammatory effects of limonin and the accompanying changes in selected mitochondrial parameters and metabolic signaling. In female C57BL/6 mice with MC903-induced atopic dermatitis-like skin inflammation, limonin reduced epidermal hyperplasia, dermal thickening, and inflammatory cytokine expression and lowered the proportions of inflammatory myeloid cells in ear skin. Limonin also suppressed Th1 and Th2 responses and altered regulatory T-cell frequencies. These effects were accompanied by a lower proportion of MitoTracker+MitoSOX+ cells, a higher proportion of MitoTracker+TMRM+ cells, and increased abundance of selected respiratory chain proteins. In IL-4/IL-13-stimulated human primary keratinocytes, limonin suppressed inflammatory chemokines and epithelial cytokines while decreasing the proportion of MitoTracker+MitoSOX+ cells and increasing the proportion of MitoTracker+TMRM+ cells. Limonin reduced the proportion of 2-NBDG-positive cells and lowered GLUT1 mRNA levels. It also increased maximal mitochondrial respiration and the abundance of selected oxidative phosphorylation subunits. These changes were accompanied by increased AMPKα Thr172 phosphorylation and decreased phosphorylation of mTOR at Ser2448, RICTOR at Thr1135, AKT at Ser473, and FOXO3a at Ser253. Cellular thermal shift assays revealed changes in mTOR and AMPKα thermal stability following limonin treatment. Limonin attenuated experimental AD-like skin inflammation and reduced inflammatory responses in cytokine-stimulated human keratinocytes, with accompanying changes in selected mitochondrial parameters and AMPK-mTOR-associated phosphorylation.
No takes yet. Share an insight, caveat, or question.
Kim et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: